Search tips
Search criteria 


Logo of rcrGuide for AuthorsAboutExplore this journalRadiology Case ReportsElsevier
Radiol Case Rep. 2007; 2(4): 109.
Published online 2015 December 7. doi:  10.2484/rcr.v2i4.109
PMCID: PMC4895866

Bone Graft Extruded From an Intramedullary Nail Tract in the Tibia


A 33-year-old man presented for follow up radiographs of the lower leg revealing dense material in the soft tissues of the ankle. These could be traced to a track in the adjacent tibia created by removal of an intramedullary nail and locking screws. This too contained dense bone graft material. The graft had migrated from the locking screw holes in the proximal tibia which had been filled approximately 2 months previously.

Abbreviations: IM, intrmedullary

Case Report

A 33-year-old man sustained a fracture of the right tibia while rollerblading approximately 18 months prior to the reported radiograph. This had been treated with an intramedullary (IM) nail. The proximal locking screws had been removed after about one year due to local pain, with good relief. Six months later the patient elected to have the nail and distal locking screws removed because of further pain, especially when kneeling. This was accomplished without complication and the proximal tibial defect was filled with a combination of synthetic bone void filler (chronOS, Synthes (USA), Paoli, PA) and demineralized bone matrix (Figure 1 A-B, Figure 1 C-D). Routine follow-up radiographs obtained 2 months following this second procedure revealed the presence of new dense material in the soft tissues of the ankle. The distal portion of the intramedullary nail track also contained the same dense granular material, but the bone graft material was not present proximally (Figure 2 A-B, Figure 2 C-D). Evidently, the bone graft material had migrated distally down the intramedullary nail tract during the intervening time, undoubtedly aided by weight-bearing activity, and then out into the soft tissues through one of the distal locking screw tracts.

Figure 1 A-B
Initial bone graft placement to fill IM nail tract. A-B, AP and Lateral radiographs of proximal tibia show bone graft material filling the proximal portion of the IM rod tract, with some pieces in the adjacent soft tissues.
Figure 1 C-D
Initial bone graft placement to fill IM nail tract. C-D, AP and Lateral radiographs of the distal tibia show the distal portion of the IM nail tract with distal locking screw tracts.
Figure 2 A-B
Heterotopic bone graft extruded through IM nail tract. A-B, AP and Lateral radiographs of the proximal tibia show that most of the bone graft material has disappeared.
Figure 2 C-D
Heterotopic bone graft extruded through IM nail tract. C-D, AP and lateral radiographs of the distal tibia show that the bone graft material has migrated to the distal portion of the IM nail tract, and that some of it has extruded through one of the distal ...


It has been shown that the screw hole is an important site of weakness following removal of hardware [1, 2]. Rosson showed that bone mass remains reduced at 18 weeks after screw removal, indicating that bone ingrowth occurs more slowly in an experimental model than in man [3]. Treatment of screw hole defects using bone graft materials has been performed. Following grafting of screw holes in dogs, the holes filled with graft material, in every case, had more bone histologically than the controls. The graft types comprised autogenous bone graft, allogenic bone graft, combined autogenous and allogenic graft and autogenous bone combined with Collagraft (porous beads containing hydroxyapatite, tricalcium phosphate and fibrillar collagen) [4].

A wide variety of graft material is available. Three properties are ideal when considering a graft material: (1) an osteoconductive matrix which acts as a scaffolding on which the process of bone formation occurs; (2) osteoinductive factors to induce osteoblast precursors to form mature bone forming cells; and (3) osteogenic cells which directly lay down new bone matrix. Autogenous bone graft has all three properties, but the disadvantages of harvest requirement and complications [5].

Demineralized bone matrix has been used alone and in combination with a variety of other agents in order to achieve a greater balance of these three properties. It has been combined with aulologous bone graft [6], and aspirated bone marrow [7, 8, 9]. It has also been combined with cancellous allograft [10, 11], and with calcium sulfate and calcium phosphate [12, 13, 14]. In our patient it was combined with Chronos (synthetic cancellous bone graft substitute containing porous beta tricalcium phosphate.)

Demineralized bone matrix is produced by acid extraction of bone. It acts primarily to provide osteoinductive growth factors and is more osteoinductive than ordinary allograft. Some osteoconductivity can be present depending on the exact details of manufacture [5, 15].

The importance of the osteoconductive scaffold has been underemphasized [16]. Good osteoconductive properties are provided by synthetic ceramics, which provide an osteoconductive scaffold to which circulating proteins such as mesenchymal stem cells and osteoinductive growth factors can adhere. They bypass the risks of allograft including immunogenic response and disease transmission [17]. Mineralization occurs and the new bone undergoes remodeling [16]. Tricalcium phosphate, has been used alone [18, 19] and has been shown to be superior to autograft in certain instances [20]. The porosity of the structure determines the surface area exposed and increases the speed of bone formation. Ultraporous tricalcium phosphate exposes the largest surface area to cells and nutrients [16, 17]. The resorption of tricalcium phosphate is approximately 10% per month with complete resorption at 6- 24 months [21].

In summary, our patient had migration of bone graft material from the proximal tibia down a nail track and into the soft tissues of the ankle. This represents a newly described cause of soft tissue heterotopic bone.


Published: October 1, 2007


1. Rosson J, Egan J, Shearer J, Monro P. Bone weakness after the removal of plates and screws. Cortical atrophy or screw holes? J Bone Joint Surg Br. 1991;73:283–286. [PubMed] [PubMed]
2. Hidaka S, Gustilo RB. Refracture of bones of the forearm after plate removal. J Bone Joint Surg Am. 1984;66:1241–1243. [PubMed] [PubMed]
3. Rosson J, Murphy W, Tonge C, Shearer J. Healing of residual screw holes after plate removal. Injury. 1991;22:383–384. [PubMed] [PubMed]
4. York MJ, Hutton WC. Treatment of screw hole defects using bone graft materials: a histologic and biomechanic study. J South Orthop Assoc. 1996;5:5–12. [PubMed] [PubMed]
5. Ludwig SC, Boden SD. Osteoinductive bone graft substitutes for spinal fusion: a basic science summary. Orthop Clin North Am. 1999;30:635–645. [PubMed] [PubMed]
6. Hierholzer C, Sama D, Toro JB, Peterson M, Helfet DL. Plate fixation of ununited humeral shaft fractures: effect of type of bone graft on healing. J Bone Joint Surg Am. 2006;88:1442–1447. [PubMed] [PubMed]
7. Tiedeman JJ, Garvin KL, Kile TA, Connolly JF. The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects. Orthopedics. 1995;18:1153–1158. [PubMed] [PubMed]
8. Wilkins RM, Chimenti BT, Rifkin RM. Percutaneous treatment of long bone nonunions: the use of autologous bone marrow and allograft bone matrix. Orthopedics. 2003;26:s549–s554. [PubMed] [PubMed]
9. Lindsey RW, Wood GW, Sadasivian KK, Stubbs HA, Block JE. Grafting long bone fractures with demineralized bone matrix putty enriched with bone marrow: pilot findings. Orthopedics. 2006;29:939–941. [PubMed] [PubMed]
10. Attias N, Lehman RE, Bodell LS, Lindsey RW. Surgical management of a long segmental defect of the humerus using a cylindrical titanium mesh cage and plates: a case report. J Orthop Trauma. 2005;19:211–216. [PubMed] [PubMed]
11. Attias N, Lindsey RW. Case reports: management of large segmental tibial defects using a cylindrical mesh cage. Clin Orthop Relat Res. 2006;450:259–266. [PubMed] [PubMed]
12. Wilkins RM, Kelly CM, Giusti DE. Bioassayed demineralized bone matrix and calcium sulfate: use in bone-grafting procedures. Ann Chir Gynaecol. 1999;88:180–185. [PubMed] [PubMed]
13. Kelly CM, Wilkins RM, Gitelis S, Hartjen C, Watson JT, Kim PT. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res. 2001:42–50. [PubMed] [PubMed]
14. Wilkins RM, Kelly CM. The effect of allomatrix injectable putty on the outcome of long bone applications. Orthopedics. 2003;26:s567–s570. [PubMed] [PubMed]
15. Stevenson S. Enhancement of fracture healing with autogenous and allogeneic bone grafts. Clin Orthop Relat Res. 1998:S239–S246. [PubMed] [PubMed]
16. Vaccaro AR. The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics. 2002;25:s571–s578. [PubMed] [PubMed]
17. Szpalski M, Gunzburg R. Applications of calcium phosphate-based cancellous bone void fillers in trauma surgery. Orthopedics. 2002;25:s601–s609. [PubMed] [PubMed]
18. Nicholas RW, Lange TA. Granular tricalcium phosphate grafting of cavitary lesions in human bone. Clin Orthop Relat Res. 1994:197–203. [PubMed] [PubMed]
19. Galois L, Mainard D, Delagoutte JP. Beta-tricalcium phosphate ceramic as a bone substitute in orthopaedic surgery. Int Orthop. 2002;26:109–115. [PubMed] [PubMed]
20. Welch RD, Zhang H, Bronson DG. Experimental tibial plateau fractures augmented with calcium phosphate cement or autologous bone graft. J Bone Joint Surg Am. 2003;85-A:222–231. [PubMed] [PubMed]
21. McAndrew MP, Gorman PW, Lange TA. Tricalcium phosphate as a bone graft substitute in trauma: preliminary report. J Orthop Trauma. 1988;2:333–339. [PubMed] [PubMed]

Articles from Radiology Case Reports are provided here courtesy of Elsevier